Lifecore Biomedical, Inc. \De\ Q3 FY2023 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2023 Q3 Call date: 2023-03-16 Concluded

Quarter scorecard

Revenue

$26.54M

-24.7% YoY

Diluted EPS

$-1.20

Gross margin

32.2%

-0.8 pp YoY

Net income

-$36.51M

Contract Development and Manufacturing Organization $18.02M

Fermentation $8.52M